Clinical Trial Update: Effects of (1,3), (1,6)-Beta-D-glucan on Insulin Sensitivity and Inflammatory Markers of the Metabolic Syndrome [NA]

View source ↗

Summary

Completed study assessing whether beta-D-glucan supplementation improves insulin sensitivity and reduces inflammatory markers in people with metabolic syndrome …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Overweight

Drugs mentioned

• Beta-D-glucan (1,3;1,6)-beta-D-glucan (beta-D-glucan)

Snippet

Sponsor: German Institute of Human Nutrition | Conditions: Overweight | NA | Status: COMPLETED